Bring the exact product information
Write down the brand, active ingredient, dose, formulation, and prescribing clinician. Include any other medicines and supplements you take.
Do not assume that advice about one GLP-1 medicine applies to every medicine in the group.
One product-specific example
The US Ozempic prescribing information directs discontinuation at least two months before a planned pregnancy because semaglutide takes time to leave the body. Discuss that instruction and your ongoing treatment needs with your prescriber before changing your medicine.
This is an example from one label, not a schedule for all GLP-1 products. A pregnancy-planning conversation also needs to address the condition being treated.
Questions for your prescriber
- Which current product information applies to my medicine?
- What needs to happen before I start trying?
- What is the plan for the condition this medicine treats?
- Do we need to discuss contraception during the transition?
- Who coordinates with my pregnancy-care clinician?
- What should I do if I think I might already be pregnant?
- Can I have the instructions and follow-up plan in writing?
Keep the plan specific
Ask which clinician is responsible for each decision. A social-media account, online calculator, or another person's timeline cannot supply that coordination.
If you are already pregnant while taking Ozempic, contact your care team promptly. The MotherToBaby semaglutide fact sheet provides background on pregnancy evidence and encourages discussion with healthcare professionals before medication changes.
Sources and further reading
Read the original guidance for its full context. These organizations do not review or endorse this website.
- Ozempic current US prescribing information (DailyMed / US National Library of Medicine)
- Semaglutide (MotherToBaby)
- Planning for Pregnancy (Centers for Disease Control and Prevention)